Form 4: Zai Lab CEO Du Ying Executes Stock Option Plan

Zai Lab Chairperson and CEO Du Ying exercised 100,000 stock options and sold the resulting shares under a pre-arranged 10b5-1 trading plan.

Summary

• Chairperson and CEO Du Ying exercised 100,000 stock options at an exercise price of $1.74 per share.
• The exercises occurred on May 13, 2026 (50,000 shares) and May 14, 2026 (50,000 shares).
• Following the exercises, the CEO sold the 100,000 shares at weighted average prices ranging from $19.44 to $20.22 per share.
• The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on November 11, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transactions were pre-planned and represent routine executive financial management.

Positives

• The transactions were conducted under a pre-established Rule 10b5-1 trading plan, indicating a systematic approach to liquidity rather than reactive selling.
• The CEO maintains a significant remaining beneficial ownership of 1,122,626 American Depositary Shares.

Negatives

• The transaction results in a reduction of the CEO's direct equity stake in the company.

Risks

• Future sales by insiders under 10b5-1 plans may influence market sentiment regarding the stock price.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives to manage personal financial planning and liquidity, and is generally viewed as neutral by the market when pre-planned.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate executives to avoid potential conflicts of interest or accusations of insider trading.
• The volume of shares sold represents a small fraction of the CEO's total holdings, consistent with typical executive diversification strategies.

Stakeholder Impact

• Minimal impact on shareholders as the transactions were executed under a pre-existing plan.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Zai Lab, ZLAB, Insider Trading, Form 4, Du Ying, Stock Options, 10b5-1